Showing posts with label Multiple sclerosis prognosis men. Show all posts
Showing posts with label Multiple sclerosis prognosis men. Show all posts

Monday, February 4, 2013

// // Leave a Comment

Multiple sclerosis prognosis

Multiple sclerosis prognosis
Multiple sclerosis is an autoimmune disease that affects the central nervous system(CNS) and is the main cause of neurological disability in young adults. The immune system incorrectly attacks healthy nerve tissue in the CNS which affects the transfer of messages from the CNS to the body.

According to estimates by the World Health Organization, about 1.3 million people worldwide are diagnosed with Multiple Sclerosis. Most of these shows first symptoms between the ages of 20 and 40. Relapsing-remitting multiple sclerosis (RRMS) is the most common form of Multiple Sclerosis, meeting in approximately 85% of cases. RRMS is characterized by acute exacerbations with full or partial recovery between attacks.

Multiple Sclerosis is a disease of young adults, the average age of onset being 29-33 years, but this area is much wider, from 10 to 59 years. With the advent of specialized diagnostic techniques such as magnetic resonance scanner (MRI), there are cases of Multiple Sclerosis diagnosed even in childhood not only in adolescence, so that, the lower age limit of 15 years expressed in specialized texts should not be seen as a fixed limit regarding Multiple Sclerosis diagnosis. Multiple Sclerosis incidence among women is higher than men by about 50%( a rate of 3 women for every 2 men).

Multiple Sclerosis is not contagious, your family and friends are safe. Multiple Sclerosis is a hereditary disease although there is a genetic predisposition, which explains the higher frequency in families. Increased risk among children and peers of people with Multiple Sclerosis may be a consequence of similar environment and a common predisposition for the disease.

 It is important to make estimates about those who are most exposed, and geographic areas with the highest incidence. Paper spread multiple sclerosis is a disease of temperate and not mainly a tropical climate. In Northern Europe, especially in Scandinavia and in Scotland there is a higher incidence of disease, reflecting a predisposition for Multiple Sclerosis among population. Migration, certainly can affect the risk of disease. Thus, a child who comes from an equatorial zone in temperate expose one risk factor from the area who moved. Migrating a teenager (or mature) keeps the risk factor of the area from which it originates.

Results of clinical trials have shown that people who start treatment after being diagnosed with multiple sclerosis have better outcomes than those who delayed treatment. However, administration of drugs has some significant drawbacks. Decision is difficult for many people with multiple sclerosis. Some prefer to wait to see if symptoms worsen before making the decision to begin treatment. A small percentage of people diagnosed with multiple sclerosis may have a few mild episodes throughout life and never develop a disability, but can not yet know who will be part of this category.

Person with Multiple Sclerosis are advised to make every effort to maintain their general health. A healthy diet, rest, use energy and intelligence practical and emotional support from family members, friends and doctor can be extremely useful.
Read More